Agitation (excessive motor or verbal activity) can be associatedoften with schizophrenia or bipolar mania, and further escalate intoaggressive behavior and potentially lead to injuries in patients andstaff. A new drug is available for the acute treatment, inhaledloxapine that allows for direct administration to the lungs, resulting in rapid absorption into the systemic circulation and rapidtranquilization.

Presenting the clinical experience with Inhaled Loxapine in thetreatment of agitation.

We haveselected representative cases of patients with a psychiatricpathology, from emergency / acute unit, characterizing theircircumstances of current admission, the intensity and the evolutionof the episodes, to evaluate the applicability and practical pointsarising from the clinical experience.

Inthe era of evidence-based practice each case report for the realclinical life adds valuable new information to the medical knowledgeof new options of treatment.